EUVIMEDEUVIMED entdecken
Open Access

An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade

Angelo Corti, Anna Maria Gasparri, Barbara Colombo, Giulia Taiè, Elisa Sangiovanni, Leopoldo Sitia, Valeria Barreca, Alice Schirru, Alessandro Gori, Luc Garrigues, Sophie Chabot, Annapaola Andolfo und 5 weitere

Theranostics · 29.07.2026 · 16 (15) · 8478-8500

DOI: 10.7150/thno.131237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 29.07.2026. Verfasst von Angelo Corti und 16 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Biology and Vascular Targeting Unit, Comprehensive Cancer Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Integrins, Antigens, Neoplasm, Transforming Growth Factor beta, Immune Checkpoint Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IntegrinsAntigens, NeoplasmTransforming Growth Factor betaImmune Checkpoint InhibitorsAnimalsHumansMiceCell Line, TumorFemaleAntineoplastic Agents

Stichwörter der Autor:innen

TGFβcancerchromogranin Apeptibodyαvβ6 and αvβ8 integrins

Substanzen

integrin alphavbeta6IntegrinsAntigens, NeoplasmTransforming Growth Factor betaintegrin alphavbeta8Immune Checkpoint InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Tumor Biology and Vascular Targeting Unit, Comprehensive Cancer Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Lymphocyte Activation Unit, Division of Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Istituto di Scienze e Tecnologie Chimiche (SCITEC-CNR), National Research Council of Italy, Milan, Italy.
  • Translational Biology, In vivo Pharmacology and Analytical Chemistry, Evotec, 195, Route D'Espagne, 31100, Toulouse, France.
  • Proteomics and Metabolomics Facility, Center for Omics Sciences, IRCCS San Raffaele, Milan, Italy.

Zitieren

APA

Corti, A., Gasparri, A. M., Colombo, B., Taiè, G., Sangiovanni, E., Sitia, L., Barreca, V., Schirru, A., Gori, A., Garrigues, L., Chabot, S., Andolfo, A., Ponzoni, M., Mondino, A., Pocaterra, A., Doglioni, C., & Curnis, F. (2026). An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade. Theranostics, 16(15), 8478-8500. https://doi.org/10.7150/thno.131237

Vancouver

Corti A, Gasparri AM, Colombo B, Taiè G, Sangiovanni E, Sitia L, et al. An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade. Theranostics. 2026;16(15):8478-8500. doi:10.7150/thno.131237

BibTeX
@article{Corti2026,
  author = {Corti, Angelo and Gasparri, Anna Maria and Colombo, Barbara and Taiè, Giulia and Sangiovanni, Elisa and Sitia, Leopoldo and Barreca, Valeria and Schirru, Alice and Gori, Alessandro and Garrigues, Luc and Chabot, Sophie and Andolfo, Annapaola and Ponzoni, Maurilio and Mondino, Anna and Pocaterra, Arianna and Doglioni, Claudio and Curnis, Flavio},
  title = {An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {15},
  pages = {8478--8500},
  doi = {10.7150/thno.131237}
}
Kostenlos starten →